JP2004065264A5 - - Google Patents

Download PDF

Info

Publication number
JP2004065264A5
JP2004065264A5 JP2003292590A JP2003292590A JP2004065264A5 JP 2004065264 A5 JP2004065264 A5 JP 2004065264A5 JP 2003292590 A JP2003292590 A JP 2003292590A JP 2003292590 A JP2003292590 A JP 2003292590A JP 2004065264 A5 JP2004065264 A5 JP 2004065264A5
Authority
JP
Japan
Prior art keywords
seq
nucleic acid
protein
calcium
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003292590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004065264A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2004065264A publication Critical patent/JP2004065264A/ja
Publication of JP2004065264A5 publication Critical patent/JP2004065264A5/ja
Withdrawn legal-status Critical Current

Links

JP2003292590A 1996-09-11 2003-08-12 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用 Withdrawn JP2004065264A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2645196P 1996-09-11 1996-09-11
US4005297P 1997-03-07 1997-03-07
US4523397P 1997-04-17 1997-04-17

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51382898A Division JP4052525B2 (ja) 1996-09-11 1997-09-10 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2006194963A Division JP2006320333A (ja) 1996-09-11 2006-07-14 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用

Publications (2)

Publication Number Publication Date
JP2004065264A JP2004065264A (ja) 2004-03-04
JP2004065264A5 true JP2004065264A5 (enExample) 2005-05-26

Family

ID=27362774

Family Applications (5)

Application Number Title Priority Date Filing Date
JP51382898A Expired - Fee Related JP4052525B2 (ja) 1996-09-11 1997-09-10 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用
JP2003292590A Withdrawn JP2004065264A (ja) 1996-09-11 2003-08-12 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用
JP2003292589A Expired - Fee Related JP4052582B2 (ja) 1996-09-11 2003-08-12 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用
JP2006194963A Pending JP2006320333A (ja) 1996-09-11 2006-07-14 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用
JP2007259280A Withdrawn JP2008092950A (ja) 1996-09-11 2007-10-02 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51382898A Expired - Fee Related JP4052525B2 (ja) 1996-09-11 1997-09-10 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2003292589A Expired - Fee Related JP4052582B2 (ja) 1996-09-11 2003-08-12 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用
JP2006194963A Pending JP2006320333A (ja) 1996-09-11 2006-07-14 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用
JP2007259280A Withdrawn JP2008092950A (ja) 1996-09-11 2007-10-02 低及び中間コンダクタンスのカルシウム活性化されたカリウムチャネル及びその使用

Country Status (8)

Country Link
US (9) US6797486B2 (enExample)
EP (1) EP0948542B1 (enExample)
JP (5) JP4052525B2 (enExample)
AT (1) ATE366260T1 (enExample)
AU (1) AU726158B2 (enExample)
CA (1) CA2265485C (enExample)
DE (2) DE69739956D1 (enExample)
WO (1) WO1998011139A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999003889A1 (en) * 1997-07-15 1999-01-28 The Regents Of The University Of California Isolated dna encoding human calcium activated potassium channel
WO1999003882A2 (en) * 1997-07-15 1999-01-28 Zeneca Limited Human leukocyte calcium activated potassium channel polypeptide
US7078184B2 (en) 2000-06-06 2006-07-18 Millennium Pharmaceuticals, Inc. 52906 Potassium channel nucleic acids and uses therefor
ATE291435T1 (de) * 2000-12-28 2005-04-15 Switch Biotech Ag Chlorzoxazon zur behandlung von psoriasis
US7022480B1 (en) * 2001-10-11 2006-04-04 The Regents Of The University Of California Exons of the hSKCa3/KCNN3 gene
US20050250090A1 (en) * 2003-10-28 2005-11-10 Edward Kaftan Assay systems and methods for detecting molecules that interact with SK2 channels
EP1884774A1 (en) * 2006-08-03 2008-02-06 INSERM (Institut National de la Santé et de la Recherche Medicale) A method for the in vitro screening of anti-cancer compounds that inhibits SK3 activity, and said anti-cancer compounds
CN110378549B (zh) * 2019-05-31 2023-05-23 广东工业大学 一种基于fahp-熵权法的输电杆塔鸟害等级评估方法
EP4695613A2 (en) * 2023-04-10 2026-02-18 Yale University Methods of modifying neurons in vivo to treat and/or prevent amyotrophic lateral sclerosis (als)
WO2025175135A1 (en) * 2024-02-15 2025-08-21 Yale University Modifying neurons to treat or prevent parkinson's disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392957B (de) 1987-08-06 1991-07-25 Technoagrar Consulting Ag Verfahren zur behandlung und entsorgung von gemengen aus feststoffen und fluessigkeiten
US6307030B1 (en) * 1988-04-15 2001-10-23 The University Of North Carolina At Chapel Hill Androgen receptor proteins, recombinant DNA molecules coding for such, and use of such compositions
CA2116280A1 (en) 1993-03-05 1994-09-06 Marcy E. Macdonald Huntingtin dna, protein and uses thereof
US5519003A (en) 1994-02-01 1996-05-21 Board Of Trustees Of The Leland Stanford Junior University WD-40-derived peptides and uses thereof
US6277978B1 (en) * 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
WO1999003889A1 (en) * 1997-07-15 1999-01-28 The Regents Of The University Of California Isolated dna encoding human calcium activated potassium channel
WO1999003882A2 (en) 1997-07-15 1999-01-28 Zeneca Limited Human leukocyte calcium activated potassium channel polypeptide
EP1052990A2 (en) 1997-11-14 2000-11-22 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction

Similar Documents

Publication Publication Date Title
JP2008249727A5 (enExample)
Bossé et al. A unique capsule locus in the newly designated Actinobacillus pleuropneumoniae serovar 16 and development of a diagnostic PCR assay
JP2008546387A5 (enExample)
AU2009205390A1 (en) Compositions and methods of detecting post-stop peptides
JP2007523089A5 (enExample)
JP2008546376A5 (enExample)
JP2009533033A5 (enExample)
CN109207503B (zh) 鸭3型腺病毒抗体间接elisa检测方法以及检测试剂盒及其应用
JP2006223304A5 (enExample)
WO2012163263A1 (en) Reagents and methods for prrsv detection
AU768992B2 (en) SRSV detection kit
JP2004500013A5 (enExample)
JP2005517414A5 (enExample)
JPH1066585A5 (enExample)
Li et al. Rapid expression of Mycobacterium avium subsp. paratuberculosis recombinant proteins for antigen discovery
CN107011417A (zh) 重组蛋白、其编码基因、其应用及猪流行性腹泻病毒抗体的检测试剂盒及检测方法
Kim et al. A one-step immunoassay based on switching peptides for diagnosis of porcine epidemic diarrhea virus (PEDV) using screened Fv-antibodies
CN103937806B (zh) 一种Rh血型DEL型RHD838G＞A等位基因及其检测方法
Pandey et al. Mammaglobin as a diagnostic serum marker of complex canine mammary carcinomas
JP2009517015A5 (enExample)
CN114773483A (zh) 非洲猪瘟病毒抗原重组串联表位蛋白及其构建方法、应用和抗体elisa试剂盒
CN111748640A (zh) 肠道菌群在肌少症中的应用
CN102827292B (zh) 一种融合蛋白TgMEP及其制备方法和应用
CN113150101A (zh) 一种恶性疟原虫RIFIN重组蛋白PfRIFIN-55的构建、制备及用途
JP2009542243A5 (enExample)